These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6093712)

  • 21. Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
    Sawada M; Matsui Y; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2421-6. PubMed ID: 6663150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the therapeutic effect of HCFU (1-hexylcarbamoyl-5-fluorouracil) on non-resectable stomach cancer].
    Sato H; Satoh H; Isono K; Onoda S; Okuyama K; Tounosu N; Yamamoto Y; Kimura M; Chin F; Kouzu T; Ryu M; Hirasawa H
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):103-8. PubMed ID: 7184358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case report of postoperative recurrent hepatocellular carcinoma effectively treated with HCFU administration combined with TAE].
    Imai Y; Ito J; Tanzawa Y; Toda N; Okamoto M; Kobayashi K; Taniguchi M; Uta Y; Tagawa K; Unuma T
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):901-4. PubMed ID: 1318699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study.
    Ono T; Nagasue N; Kohno H; Hayashi T; Uchida M; Yukaya H; Yamanoi A
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-18-S6-25. PubMed ID: 9151912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil.
    Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Chemother Pharmacol; 1980; 4(2):83-7. PubMed ID: 7389060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil.
    Kusumoto T; Maehara Y; Sakaguchi Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):477-81. PubMed ID: 2703002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer].
    Wada S; Yasumoto R; Kashihara N; Kishimoto T; Maekawa M; Hayahara N; Kawakita J; Nishijima T; Morikawa Y; Horii A
    Hinyokika Kiyo; 1992 Jan; 38(1):19-24. PubMed ID: 1546564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
    Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil.
    Nakanishi H; Abe A; Inada K; Tsukamoto T; Yasui K; Tatematsu M
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):660-8. PubMed ID: 10592098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of urokinase on the transfer of 1-hexylcarbamoyl-5-fluorouracil (HCFU) into the blood, bile and pancreatic juice].
    Kato S; Matsuno S; Kakizaki K; Fukaya Y; Akaishi S
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2134-8. PubMed ID: 4062312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitro.
    Maehara Y; Kusumoto H; Anai H; Kusumoto T; Hiramoto Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1511-5. PubMed ID: 3678315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic fate of 1-hexylcarbamoyl-5-fluorouracil after oral administration in mice.
    Iigo M; Nakamura A; Kuretani K; Hoshi A
    Xenobiotica; 1980 Nov; 10(11):847-54. PubMed ID: 7467400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro.
    Tsumura M; Yoshiga K; Takada K
    Cancer Res; 1988 Jul; 48(14):3977-80. PubMed ID: 3383192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases.
    Link JS; Bateman JR; Paroly WS; Durkin WJ; Peters RL
    Cancer; 1977 May; 39(5):1936-9. PubMed ID: 192441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Improvement of stability and bioavailability of 1-hexylcarbamoyl-5-fluorouracil (HCFU) by O-carboxymethyl-O-ethyl-beta- cyclodextrin].
    Horiuchi Y; Hirayama F; Uekama K
    Yakugaku Zasshi; 1991 Oct; 111(10):592-9. PubMed ID: 1812279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
    Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
    Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.
    Ikeda M; Okusaka T; Ueno H; Takezako Y; Morizane C
    Cancer; 2005 Feb; 103(4):756-62. PubMed ID: 15637692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 1-hexylcarbamoyl-5-fluorouracil on development of rat urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ozono S; Iwata H; Tsunemi K; Takahashi S; Matsuki H; Sasaki K; Hirao Y; Okajima E
    Jpn J Exp Med; 1988 Jun; 58(3):123-7. PubMed ID: 3184501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of oral carmofur in advanced pancreatic carcinoma.
    Kajanti MJ; Pyrhönen SO
    Ann Oncol; 1991; 2(10):765-6. PubMed ID: 1801884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.